AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsHealth Care
Angiotensin IIReceptor, Angiotensin, Type 1Receptors, AngiotensinAngiotensin II Type 1 Receptor BlockersReceptor, Angiotensin, Type 2Angiotensin Receptor AntagonistsAngiotensin ILosartanTetrazolesAngiotensin II Type 2 Receptor BlockersAngiotensin IIIAngiotensin-Converting Enzyme InhibitorsBiphenyl CompoundsSaralasin1-Sarcosine-8-Isoleucine Angiotensin IIPeptidyl-Dipeptidase AImidazolesReninBenzimidazolesVasoconstrictor AgentsBlood PressureAngiotensinsAntihypertensive AgentsAldosteroneHypertensionRats, Sprague-DawleyKidneyAngiotensinogenRenin-Angiotensin SystemPyridinesEnalaprilMuscle, Smooth, VascularRats, Inbred SHRCells, CulturedRats, Inbred WKYVasoconstrictionRenal CirculationDose-Response Relationship, DrugTeprotideHypertension, RenalEnalaprilatValineCaptoprilNorepinephrineRats, WistarRNA, MessengerChymasesAngiotensin AmideAortaBenzoatesMyocardiumBradykininCardiomegalyLisinoprilDiet, Sodium-RestrictedAdrenal GlandsNADPH OxidaseSubfornical OrganDrinkingVasopressinsHypertrophyHemodynamicsFibrosisHypertension, RenovascularHydralazineSodiumSignal TransductionDisease Models, AnimalVascular ResistanceArginine VasopressinHeart RateRats, Inbred StrainsSympathetic Nervous SystemKidney Tubules, ProximalZona GlomerulosaAorta, ThoracicSodium Chloride, DietaryPhenylephrineNitric OxideTime FactorsOligopeptidesInfusion Pumps, ImplantableNatriuresisGlutamyl AminopeptidaseCalciumRamiprilEnzyme InhibitorsNephrectomyRabbitsKidney GlomerulusMesenteric ArteriesMice, Inbred C57BLKidney CortexAtrial Natriuretic FactorEndothelin-1Aldosterone SynthaseHeartThiazepinesMice, KnockoutEndothelium, Vascular
ACE2CarboxypeptidaseInhibitors or angiotensin receptor blockersARBsInhibitorEffects of angiotensinAbstractReninSevere acute respiAngiotensinogenHACE2ProteinConverting enzyme inhibitorsCoronavirus disease 2019Conversion of angiotensinReceptorsRespiratoryInfectionGeneHypertensionPeptideConvertsActive octapeptidePathogenesisMyocardial infarction2019Outcome2021PatientsSubstrateADAM17DeletionFunctionalSARS-CoVAstrocytesCleavageHumanAtheroscleroticEpithelial cellsBlood vesselsKidneysSympatheticGenotypes
ACE259
  • Angiotensin-converting enzyme 2 (ACE2) is an enzyme that can be found either attached to the membrane of cells (mACE2) in the intestines, kidney, testis, gallbladder, and heart or in a soluble form (sACE2). (wikipedia.org)
  • Both membrane bound and soluble ACE2 are integral parts of the renin-angiotensin-aldosterone system (RAAS) that exists to keep the body's blood pressure in check. (wikipedia.org)
  • While mACE2 does not appear to factor into the harmful phase of RAAS (the increase of blood pressure), its existence is vital in order for the enzyme ADAM17 to cleave its extracellular domain to create soluble ACE2 (sACE2). (wikipedia.org)
  • Soluble ACE2 lowers blood pressure by catalyzing the hydrolysis of angiotensin II (a vasoconstrictor peptide) into angiotensin (1-7) (a vasodilator) which in turns binds to MasR receptors creating localized vasodilation and hence decreasing blood pressure. (wikipedia.org)
  • The SARS-CoV-2 spike protein itself is known to damage the endothelium via downregulation of ACE2. (wikipedia.org)
  • ACE2 has an opposing effect to ACE, degrading angiotensin II into angiotensin (1-7), thereby lowering blood pressure. (wikipedia.org)
  • A protein called ACE2 is intimately involved in how SARS-CoV-2, the virus that causes COVID-19, infects the body. (pharmalive.com)
  • Coat the plate with 0.2μg/well (2μg/ml, 100μl/well) of SARS-CoV-2 S1 protein (CSB-MP3324GMY), add 100μl/well (0.7629-100000ng/ml, gradient dilution, 2x to 18x) of ACE2 protein and 100μl/well of Peroxidase-Affinipure Goat Anti-Human IgG, Fcγ Fragment Specific (CSB-PA160506). (joplink.net)
  • The results showed SARS-CoV-2 S1 protein could bind ACE2 protein. (joplink.net)
  • The EC50 is 8.363-12.82 ng/ml ng/ml. ⑤The SPR sensorgram shows the binding between ACE2 protein (CSB-MP866317HU) and SARS-CoV-2 S1-RBD protein (CSB-YP3324GMY1). (joplink.net)
  • ACE2 protein was injected at 5 concentrations (400, 200, 100, 50, 0 nM) across 0.5 mg/ml of SARS-CoV-2 S1-RBD protein captured on a COOH chip. (joplink.net)
  • The results showed ACE2 protein could bind SARS-CoV-2 S1-RBD protein with an affinity constant of 100 nM. (joplink.net)
  • ⑥The SPR sensorgram shows the binding between ACE2 protein (CSB-MP866317HU) and SARS-CoV-2 S1-RBD protein (CSB-MP3324GMY1b1). (joplink.net)
  • Recombinant Angiotensin I Converting Enzyme 2 (ACE2) is Available at Gentaur Genprice with the fastest delivery. (proteomecommons.org)
  • Mice are refractory to SARS-CoV-2 infection owing to low-affinity binding to the murine angiotensin-converting enzyme 2 (ACE2) protein. (jci.org)
  • Here, we evaluated the pathogenesis of SARS-CoV-2 in male and female mice expressing the human ACE2 gene under the control of the keratin 18 promoter (K18). (jci.org)
  • The binding of SARS-CoV spike (S) protein to cellular angiotensin-converting enzyme 2 (ACE2) is the first step in SARS-CoV infection. (scienceopen.com)
  • SP-4 (residues 192-203), SP-8 (residues 483-494), and SP-10 (residues 668-679) significantly blocked the interaction between S protein and ACE2 by biotinylated enzyme-linked immunosorbent assay, with IC 50 values of 4.30 ± 2.18, 6.99 ± 0.71, and 1.88 ± 0.52 nmol, respectively. (scienceopen.com)
  • ACE2 converts angiotensin II (Ang1-8) to angiotensin 1-7 (Ang1-7), with Ang1-7 acting as a functional antagonist of Ang1-8. (guidetopharmacology.org)
  • Enhancing ACE2 activity by exogenous administration of ACE2 might be beneficial in human diseases with pathologically elevated Ang1-8, such as may occur when ACE2 is disrupted during the SARS-CoV-2 infection process. (guidetopharmacology.org)
  • Soluble human ACE2, either exogenous recombinant protein or upregulated release of membrane bound endogenous ACE2 via activation of the sheddase ADAM17, could act as a decoy for SARS-CoV-2 viruses, as potential mechanisms to combat infection and/or pathophysiological effects [ 13 ]. (guidetopharmacology.org)
  • Angiotensin-converting enzyme-related carboxypeptidase (ACE2) is a recently identified zinc metalloprotease with carboxypeptidase activity that was identified using our genomics platform. (acs.org)
  • Effect of an Inhibitor on the ACE2-Receptor-Binding Domain of SARS-CoV-2. (acs.org)
  • An Active Site Inhibitor Induces Conformational Penalties for ACE2 Recognition by the Spike Protein of SARS-CoV-2. (acs.org)
  • It has been known for many years that the angiotensin-converting enzyme 2 (ACE2) is a cell surface enzyme involved in the regulation of blood pressure. (hal.science)
  • More recently, it was proven that the severe acute respiratory syndrome coronavirus (SARS-CoV-2) interacts with ACE2 to enter susceptible human cells. (hal.science)
  • At the very start of the pandemic, a publication from our Institute (entitled "ACE2 receptor polymorphism: susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome"), was one of the first reviews linking COVID-19 to the duplicitous nature of ACE2. (hal.science)
  • However, even given that COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin system (RAS), we were still far from understanding the complexity of the mechanisms which are controlled by ACE2 in different cell types. (hal.science)
  • To gain insight into the physiopathology of SARS-CoV-2 infection, it is essential to consider the polymorphism and expression levels of the ACE2 gene (including its alternative isoforms). (hal.science)
  • Over the past 2 years, an impressive amount of new results have come to shed light on the role of ACE2 in the pathophysiology of COVID-19, requiring us to update our analysis. (hal.science)
  • In this review, we update the state of knowledge on the polymorphism of ACE2 and its consequences on the susceptibility of individuals to SARS-CoV-2. (hal.science)
  • Background: Angiotensin converting enzyme 2 (ACE2) protein serves as the host receptor for SARS-CoV-2, with a critical role in viral infection. (ubc.ca)
  • We aim to understand population level variation of nasopharyngeal ACE2 transcription in people tested for COVID-19 and the relationship between ACE2 transcription and SARSCoV-2 viral load, while adjusting for expression of: (i) the complementary protease, Transmembrane serine protease 2 (TMPRSS2), (ii) soluble ACE2, (iii) age, and (iv) biological sex. (ubc.ca)
  • Bivariate analysis and multiple linear regression were performed to understand the role of nasopharyngeal ACE2 expression in SARS-CoV-2 infection. (ubc.ca)
  • Interpretation: Nasopharyngeal ACE2 transcription plays a dual, contrasting role in SARS-CoV-2 infection of the upper respiratory tract. (ubc.ca)
  • Immature angiotensin converting enzyme (ACE2) interferes with coronavirus entry into the cells. (thieme-connect.com)
  • Angiotensin-converting enzyme (ACE2) has a multiplicity of physiological roles that revolve around its trivalent function: a negative regulator of the renin-angiotensin system (RAS), facilitator of amino acid transport, and the SARS-CoV and SARS-CoV-2 receptor. (softwavetrt.com)
  • ACE2 has recently been identified as the SARS-CoV-2 receptor, the infective agent responsible for COVID-19, providing a critical link between immunity, inflammation, ACE2, and cardiovascular disease. (softwavetrt.com)
  • Although sharing a close evolutionary relationship with SARS-CoV, the receptor-binding domain of SARS-CoV-2 differs in several key amino acid residues, allowing for stronger binding affinity with the human ACE2 receptor, which may account for the greater pathogenicity of SARS-CoV-2. (softwavetrt.com)
  • The measurements were performed in black microtiter plates with a total volume of 100 ul as described previously in detail20 37 To study the effect of XNT and DIZE on enzyme activity of purified ACE2 these compounds were added in quadruplicate at 10? (academicediting.org)
  • Measurements of Ang II degradation in vitro Ang II was incubated at 37°C with either 200ng/mL or 800ng/ml of recombinant ACE2 in the presence of XNT or DIZE for a period of 4 hours. (academicediting.org)
  • Aligned ACE2 protein sequences from human, rhesus macaque, African green monkey, cat, dog, American mink, mouse, and chicken cells in study of susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) of cell lines and substrates used to diagnose and isolate influenza and other viruses. (cdc.gov)
  • ACE2 is expressed in the human placenta, but its regulation in relation to maternal SARS-CoV-2 infection in pregnancy is not well understood. (johnshopkins.edu)
  • This study evaluated ACE2 expression, ADAM17 activity, and serum ACE2 abundance in a cohort of matched villous placental and maternal serum samples from control pregnancies (SARS-CoV-2 negative, n = 8) and pregnancies affected by symptomatic maternal SARS-CoV-2 infections in the second trimester [2nd Tri coronavirus disease (COVID), n = 8] and third trimester (3rd Tri COVID, n = 8). (johnshopkins.edu)
  • These data suggest that in acute maternal SARS-CoV-2 infections, decreased placental ACE2 protein may be the result of ACE2 shedding and highlights the importance of ACE2 for studies on SARS-CoV-2 responses at the maternal-fetal interface. (johnshopkins.edu)
  • Angiotensin‐converting enzyme 2 (ACE2) is the entry receptor for severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2), the cause of Coronavirus Disease‐2019 (COVID‐19) in humans. (units.it)
  • ACE2 mediates the interaction between host cells and SARS‐CoV‐2 spike (S) protein. (units.it)
  • However, ACE2 is not only a SARS‐CoV‐2 receptor, but it has also an important homeo-static function regulating renin‐angiotensin system (RAS), which is pivotal for both the cardiovascular and immune systems. (units.it)
  • Therefore, ACE2 is the key link between SARS‐CoV‐2 infection, cardiovascular diseases (CVDs) and immune response. (units.it)
  • Susceptibility to SARS‐CoV‐2 seems to be tightly associated with ACE2 availability, which in turn is determined by genetics, age, gender and comor-bidities. (units.it)
  • In spite of a lower ACE2 expression on cells surface, patients with CVDs have a higher COVID‐19 mortality rate, which is likely driven by the imbalance between ADAM metallopeptidase domain 17 (ADAM17) protein (which is required for cleavage of ACE‐2 ectodomain resulting in increased ACE2 shedding), and TMPRSS2 (which is required for spike glycoprotein priming). (units.it)
  • An additional key player in COVID-19 is the enzyme, angiotensin-converting enzyme 2 (ACE2), which is essential for adhesion and uptake of virus into cells prior to replication. (uhi.ac.uk)
  • It was proven that human ACE2 is the main receptor for the entry of Covid-19 into lower respiratory tract epithelial cells through interaction with SARS-CoV-2 S protein. (nih.gov)
  • In this study, using structure-based virtual screening of FDA databases, several lead drugs were discovered based on the ACE2-binding pocket of SARS-CoV-2 S protein. (nih.gov)
  • Histopathology and localization of SARS-CoV-2 and its host cell entry receptor ACE2 in tissues from naturally infected US- farm ed mink (Neovison vison). (cdc.gov)
  • We characterized the pathological findings in 72 mink from US farm s with SARS-CoV-2 outbreaks, localized SARS-CoV-2 and its host cellular receptor angiotensin-converting enzyme 2 (ACE2) in mink respiratory tissues, and evaluated the utility of various test methods and specimens for SARS-CoV-2 detection in necropsy tissues. (cdc.gov)
  • The SARS-CoV-2 receptor ACE2 was extensively detected by IHC within turbinate epithelium, with decreased detection in lower respiratory tract epithelium and alveolar macrophages. (cdc.gov)
  • They identified a new association with a rare genetic variant at the Xp22.2 locus (rs190509934) that downregulates the expression of angiotensin-converting enzyme 2 (ACE2). (cdc.gov)
  • The number of children infected with SARS-CoV-2 is relatively small, perhaps due to the lower expression of Angiotensin Converting Enzyme 2 (ACE2) in children compared to adults. (bvsalud.org)
Carboxypeptidase1
Inhibitors or angiotensin receptor blockers1
  • The general approach to therapy of ischemic nephropathy involves control of hypertension, preferably with angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs). (medscape.com)
ARBs6
  • For management of heart failure with reduced ejection fraction (HFrEF), medication classes consist of diuretics, angiotensin-receptor blockers (ARBs), angiotensin-converting enzyme (ACE) inhibitors, and beta-blockers. (medscape.com)
  • We conducted a meta-analysis to explore the benefits of angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin II receptor blockers (ARBs) combined with calcium channel blockers (CCBs) on metabolic, renal, and cardiovascular outcomes in hypertensive patients. (unboundmedicine.com)
  • The relative effectiveness of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) for lowering blood pressure is unknown. (qxmd.com)
  • Background: Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) have anti-inflammatory and immuno-modulating properties which are effective in the treatment of cardiovascular disease and in suppressing the symptoms of ongoing autoimmunity. (uu.nl)
  • To date, ACE inhibitors and Angio-tensin II Receptor Blockers (ARBs) treatment interruption in patients with chronic comorbidities appears unjustified. (units.it)
  • Angiotensin II receptor blockers (also called ARBs ) reduce the action of angiotensin II in your body. (medlineplus.gov)
Inhibitor4
  • Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist. (unil.ch)
  • How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure? (bmj.com)
  • OBJECTIVE Angiotensin II (AII) and aldosterone are not always fully suppressed during chronic angiotensin converting enzyme (ACE) inhibitor treatment. (bmj.com)
  • 2 , 3 However, the reductions in angiotensin II (AII) and aldosterone may not be maintained with chronic ACE inhibitor treatment. (bmj.com)
Effects of angiotensin5
Abstract2
  • abstract = "Meta-analyses have indicated that individuals with type 1 or type 2 diabetes are atincreased risk of suffering a severe form of COVID-19 and have a higher mortality rate than the non-diabetic population. (uhi.ac.uk)
  • ABSTRACT Using data from the 2nd Gulf Registry of Acute Coronary Events (Gulf RACE-2) in 2008-09 we investigated the in-hospital complications and 1-year outcome of acute coronary syndrome (ACS) in patients with systemic hypertension from 6 Gulf countries. (who.int)
Renin16
Severe acute respi6
  • The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic of novel corona virus disease (COVID-19). (medrxiv.org)
  • severe acute respiratory syndrome coronavirus 2 from patient with coronavirus disease, United States. (cdc.gov)
  • US CDC Real-time reverse transcription PCR panel for detection of severe acute respiratory syndrome coronavirus 2. (cdc.gov)
  • While the human placenta may be infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the rate of fetal transmission is low, suggesting a barrier at the maternal-fetal interface. (johnshopkins.edu)
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes respiratory disease in mink similar to human COVID-19. (cdc.gov)
  • This paper was prepared in response to the need for clear communication regarding the risk of transmission of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19 in humans and the general societal concern of potential contamination of aquatic animals used as food or their products with the virus. (who.int)
Angiotensinogen2
  • The brain has shown the presence of various components of brain RAS such as angiotensinogen (AGT), converting enzymes, angiotensin (Ang), and specific receptors (ATR). (hindawi.com)
  • Intrinsic brain RAS is an enzyme-neuropeptide system having functional components (angiotensinogen, peptidases, angiotensin, and specific receptor proteins) with important biological and neurobiological activities in the brain. (hindawi.com)
HACE25
  • The human version of the enzyme can be referred to as hACE2. (wikipedia.org)
  • Here we report two monoclonal antibodies (mAbs) cloned from memory B cells of patients recently recovered from COVID-19, and both mAbs specifically bind to the spike (S) protein of SARS-CoV-2, block the binding of receptor binding domain (RBD) of SARS-CoV-2 to human angiotensin converting enzyme 2 (hACE2), and effectively neutralize S protein-pseudotyped virus infection. (medrxiv.org)
  • In contrast to nontransgenic mice, intranasal exposure of K18-hACE2 animals to 2 different doses of SARS-CoV-2 resulted in acute disease, including weight loss, lung injury, brain infection, and lethality. (jci.org)
  • We previously identified the causative agent as a novel SARS-related coronavirus ( SARS-CoV-2 ) that uses human angiotensin-converting enzyme 2 (hACE2) as the entry receptor. (bvsalud.org)
  • Here, we successfully developed a SARS-CoV-2 hACE2 transgenic mouse (HFH4-hACE2 in C3B6 mice ) infection model. (bvsalud.org)
Protein9
  • The expression profile of mACE2 in the human body was recently thoroughly evaluated by the Human Protein Atlas team using a large-scale multiomics approach combining several different methods for analysis of gene expression, including a stringent immunohistochemical analysis using two independent antibodies. (wikipedia.org)
  • Despite the fact that the respiratory system is the primary route of SARS-CoV-2 infection, very limited expression is seen, both at protein and mRNA level. (wikipedia.org)
  • As a transmembrane protein, mACE2 serves as the main entry point into cells for some coronaviruses, including HCoV-NL63, SARS-CoV (the virus that causes SARS), and SARS-CoV-2 (the virus that causes COVID-19). (wikipedia.org)
  • cov S1 Protein Activity: Immobilized Human ACE-2-Fc. (proteomecommons.org)
  • 2019-nCoV S RBD Protein Activity: Immobilized Human ACE-2-FC (Cat#PKSR030492) at 10μg/ml. (proteomecommons.org)
  • Specifically Binding to the microplates pre-coated by SARS-CoV-2 Spike Protein RBD-mFc Fusion (HEK293). (aviscerabioscience.net)
  • Hoffmann M , Kleine-Weber H , Pöhlmann S . A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. (cdc.gov)
  • Angiotensin II constricts arteries and veins by binding to AT 1 receptors on the smooth muscle, which are coupled to a Gq-protein and the IP 3 signal transduction pathway . (cvpharmacology.com)
  • The catalytic efficiency is 400-fold higher with ANGIOTENSIN II as a substrate than with ANGIOTENSIN I. Angiotensin-converting enzyme 2 is also is a functional receptor for the spike glycoprotein (SPIKE PROTEIN, CORONAVIRUS) of the CORONAVIRUSES SARS-COV, SARS-COV2, and HCOV-NL63. (bvsalud.org)
Converting enzyme inhibitors3
Coronavirus disease 20191
  • Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms. (cdc.gov)
Conversion of angiotensin2
Receptors2
  • It is released into the bloodstream where one of sACE2's functions is to turn excess angiotensin II into angiotensin 1-7 which binds to MasR receptors creating localized vasodilation and hence decreasing blood pressure. (wikipedia.org)
  • sACE2, as part of RAAS's protective phase, cleaves the carboxyl-terminal amino acid phenylalanine from angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) and hydrolyses it into the vasodilator angiotensin (1-7) (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH), which binds to Mas Receptors and ultimately leads to a decrease in blood pressure. (wikipedia.org)
Respiratory5
  • One hundred years after the 1918 influenza pandemic, we now face another pandemic with the severe acute respiratory syndrome-novel coronavirus-2 (SARS-CoV-2). (thieme-connect.com)
  • We therefore analyzed pharmacological/pharmacodynamic effects of isotonic or hypertonic saline, relevant to SARS-CoV-2 infection and respiratory care. (springer.com)
  • Kim D , Quinn J , Pinsky B , Shah NH , Brown I . Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. (cdc.gov)
  • Coinfection with SARS-CoV-2 and other respiratory pathogens in patients with COVID-19 in Guangzhou, China. (cdc.gov)
  • In formalin-fixed paraffin-embedded (FFPE) upper respiratory tract (URT) specimens, conventional reverse transcription-polymerase chain reaction (cRT-PCR) was more sensitive than in situ hybridization (ISH) or immunohistochemistry (IHC) for detection of SARS-CoV-2. (cdc.gov)
Infection11
  • According to a study published in the journal Science Advances, an international team of researchers led by neuroscientists at Harvard Medical School uncovered which olfactory cell types are most vulnerable to infection by SARS-CoV-2, which causes Covid-19. (pharmalive.com)
  • To our knowledge, this is the first highly lethal murine infection model for SARS-CoV-2 and should be valuable for the study of SARS-CoV-2 pathogenesis and for the assessment of MCMs. (jci.org)
  • There is considerable variability in the incidence of infection and severe disease following exposure to SARS-CoV-2. (thieme-connect.com)
  • The low severity of SARS-CoV-2 infection in this population is associated with a high incidence of asymptomatic or mildly symptomatic infection making them efficient carriers. (thieme-connect.com)
  • The epidemiology and clinical characteristics of co-infection of SARS-CoV-2 and influenza viruses in patients during COVID-19 outbreak. (cdc.gov)
  • Host and viral determinants for efficient SARS-CoV-2 infection of the human lung. (cdc.gov)
  • This study expands on the knowledge of the pathology and pathogenesis of natural SARS-CoV-2 infection in mink and supports their further investigation as a potential animal model of SARS-CoV-2 infection in humans. (cdc.gov)
  • This finding pointed to the importance of interferons (IFNs), during the initial infection, for clearing SARS-CoV-2 and concerns about using glucocorticoids, which could inhibit IFN signaling in COVID-19 treatment. (cdc.gov)
  • The proactive approach to international collaboration and sharing of resources have enabled the discovery of previously unknown pathophysiological mechanisms of SARS-CoV-2 infection and revealed the complex genetic architecture of COVID-19. (cdc.gov)
  • While we have made an impressive sprint to uncover the genetic anchors for response to COVID-19 infection just two years into the pandemic, the next major challenge is to use these biologic findings to inform treatment and prevention. (cdc.gov)
  • In adults, olfactory loss is one of the earliest and most frequent acute clinical manifestations of SARS-CoV-2 infection. (bvsalud.org)
Gene4
  • Patients carrying the D allele of the angiotensin I converting enzyme (ACE) gene had greater coronary extent scores (defined as the number of coronary segments with 5% to 75% stenosis) than those not carrying this allele (p = 0.006 in non-parametric analysis and p = 0.019 in parametric analysis). (bmj.com)
  • The D allele of angiotensin I-converting enzyme gene insertion/deletion polymorphism is associated with the severity of atherosclerosis" Clinical Chemistry and Laboratory Medicine , vol. 46, no. 4, 2008, pp. 446-452. (degruyter.com)
  • Niemiec, P., Zak, I. and Wita, K. (2008) The D allele of angiotensin I-converting enzyme gene insertion/deletion polymorphism is associated with the severity of atherosclerosis. (degruyter.com)
  • For example, two variants of IFNAR2 , a gene involved in the pathway for early immune response to viral infections, are associated with severe COVID-19. (cdc.gov)
Hypertension8
  • The goal of medication treatment of group 2 pulmonary hypertension is to lower filling pressures and provide afterload reduction in patients with heart failure. (medscape.com)
  • Approved for use in group 1 pulmonary arterial hypertension, there have been few trials evaluating their efficacy in group 2 pulmonary hypertension. (medscape.com)
  • Pioneering studies on ACE were oriented towards understanding the etiology of hypertension, a disease in which Ang II plays a crucial role. (nova.edu)
  • Inhibition of Angiotensin Converting Enzyme (ACE) is a modern therapeutic target in the treatment of hypertension. (scielo.br)
  • After 5 minutes of baseline SBP recording acute hypertension in anesthetized mice was induced with an IP bolus of Ang II (0.2 mg/kg) and the SBP was monitored for the remaining 20 minutes. (academicediting.org)
  • Mass spectrometry Please see Online Supplement Results Effect of XNT on hypertension acutely induced by Ang II infusion in WT mice The effect of XNT on blood pressure was examined in studies in C57BL6 WT mice following a bolus of Ang II to induce acute hypertension. (academicediting.org)
  • diovascular disease, including stroke, RACE-2, which was a 9-month prospec- Systemic hypertension was defined in coronary artery disease (CAD), heart tive, multicentre study of 7847 consecu- the current registry as: either history of failure and peripheral vascular dis- tive patients with ACS from 6 adjacent hypertension diagnosed and treated ease [1-3]. (who.int)
  • A 5 cm larger WC at baseline increased the risk of developing hypertension at follow-up only in women (odds ratio, 1.56 [95% CI, 1.15-2.10], P=0.004) and in II genotype carriers (odds ratio, 1.87 [95% CI, 1.09-3.20], P=0.023). (lu.se)
Peptide2
  • Structure-Guided Chemical Optimization of Bicyclic Peptide (Bicycle) Inhibitors of Angiotensin-Converting Enzyme 2. (acs.org)
  • Development of Potent and Selective Phosphinic Peptide Inhibitors of Angiotensin-Converting Enzyme 2. (acs.org)
Converts1
  • Angiotensin-converting enzyme (ACE) converts Ang I into angiotensin II (Ang II) which acts on an angiotensin type 1 (AT1) and angiotensin type 2 (AT2) receptor. (hindawi.com)
Active octapeptide1
  • Background: ACE is a zinc-dependent peptidase responsible for converting Ang I into the biologically active octapeptide Ang II. (nova.edu)
Pathogenesis2
  • Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2. (bvsalud.org)
  • Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis. (cdc.gov)
Myocardial infarction1
  • Any history of first myocardial infarction [2]. (who.int)
20192
  • SARS-CoV-2 was referred to as 2019-nCoV, or Wuhan coronavirus prior to formal naming by the International Committee on Taxonomy of Viruses (ICTV). (guidetopharmacology.org)
  • Yugandhar, Vudhya G. and Clark, Michelle A., "Effects of Ang II on Angiotensin Converting Enzyme mRNA Expression in Cultured Rat Astrocytes" (2019). (nova.edu)
Outcome1
  • In this study, 1613 patients were randomized to bosentan versus placebo, with results showing no improvement in outcome between the two groups. (medscape.com)
20212
Patients7
  • We also discuss the link between the increase of angiotensin II levels among SARS-CoV-2-infected patients and the development of a cytokine storm associated microvascular injury and obstructive thrombo-inflammatory syndrome, which represent the primary causes of severe forms of COVID-19 and lethality. (hal.science)
  • Angiotensin receptor blockers are widely used in patients at high risk of cardiocerebrovascular events. (nih.gov)
  • D allele carriers ( DD+ID genotypes) were more frequent in the subgroup of patients with stenoses in at least four coronary vessels than in other patients including subjects with one-, two- and three-vessel disease (97.4% vs. 74.4%, OR=13.05, 95% CI: 1.81-100.00, χ 2 =9.84, p=0.0017). (degruyter.com)
  • It is also not known whether patients with chronic liver disease such as viral hepatitis B and/or C may be more susceptible to liver damage from SARS-CoV-2, as was noted with the earlier SARS-CoV virus . (medscape.com)
  • RÉSUMÉ À partir de données du deuxième Registre des événements coronariens aigus du Golfe (Gulf RACE-2), pour la période 2008 - 2009, nous avons enquêté sur les complications à l'hôpital et sur l'issue à un an d'un syndrome coronarien aigu chez des patients atteints d'hypertension artérielle systémique dans six pays du Golfe. (who.int)
  • Chez les patients hypertendus, le taux de mortalité était plus élevé uniquement chez les patients admis pour un infarctus du myocarde avec sus-décalage du segment ST. Après ajustement des résultats en fonction des variables de référence, l'hypertension s'est révélé être un facteur prédictif indépendant de l'insuffisance cardiaque (OR = 1,31) et de l'accident vasculaire cérébral (OR = 2,47). (who.int)
  • To investigate whether the use of statin is associated with a risk reduction in lower-extremity amputation in type 2 diabetes mellitus (DM) patients with peripheral arterial disease (PAD). (medscape.com)
Substrate3
  • The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. (caslab.com)
  • An ACE-2 (Angiotensin I-converting enzyme 2) fluorescent substrate. (mobitec.com)
  • Effect of XNT and DIZE on enzyme activity of recombinant Aminopeptidase A The effect of XNT and DIZE on enzyme activity of human recombinant aminopeptidase A (APA) (R&D Systems) was studied using synthetic specific substrate H-Glu-AMC (Bachem Americas). (academicediting.org)
ADAM171
  • Angiotensin-converting enzyme (ACE)2, the main receptor for SARS-CoV-2, is regulated by a metalloprotease cleavage enzyme, a disintegrin and metalloprotease domain 17 (ADAM17). (johnshopkins.edu)
Deletion1
  • We aimed to identify the relationship between adiposity and blood pressure, independent of a robust set of lifestyle and metabolic factors, and to examine the modulating role of sex and Angiotensin-Converting Enzyme (ACE) insertion/deletion (I/D) polymorphisms. (lu.se)
Functional1
  • SARS-CoV-2 binds to target cells through a functional receptor , angiotensin-converting enzyme 2, which is present on biliary and liver epithelial cells. (medscape.com)
SARS-CoV26
  • mACE2 also serves as the entry point into cells for some coronaviruses, including HCoV-NL63, SARS-CoV, and SARS-CoV-2. (wikipedia.org)
  • iBio Inc. is developing a decoy molecule as a therapeutic against SARS-CoV-2. (pharmalive.com)
  • The emergence of SARS-CoV-2 has created an international health crisis, and small animal models mirroring SARS-CoV-2 human disease are essential for medical countermeasure (MCM) development. (jci.org)
  • Virus identical to SARS-CoV-2 in full- genome sequences was isolated from the infected lung and brain tissues . (bvsalud.org)
  • Last, we showed that pre-exposure to SARS-CoV-2 could protect mice from severe pneumonia . (bvsalud.org)
  • Coronaviruses and SARS-CoV-2 damage ciliated epithelium in the nose and airways. (springer.com)
  • Recently, also the Deutsche Gesellschaft für Krankenhaushygiene (DGKH) has formulated gargling/rinse measures to contain SARS-CoV-2 transmission in household, nursing homes, and schools [ 9 ]. (springer.com)
  • We therefore investigated the mechanisms by which saline nasal spray/irrigation or aerosol may limit SARS-CoV-2 infectivity and spread. (springer.com)
  • An infectious cDNA clone of SARS-CoV-2. (cdc.gov)
  • SARS-CoV-2 spike D614G variant confers enhanced replication and transmissibility. (cdc.gov)
  • Most recently, the new coronavirus (SARS-CoV-2) has been recognized as a pandemic by the World Health Organization (WHO) while this virus shares substantial similarity with SARS-CoV. (nih.gov)
  • Of SARS-CoV-2-positive animals found dead, 74% had bronchiolitis and diffuse alveolar damage (DAD). (cdc.gov)
  • similar findings were seen in SARS-CoV-2-negative animals. (cdc.gov)
  • Suppurative rhinitis, lymphocytic perivascular inflammation in the lungs, and lymphocytic infiltrates in other tissues were common in both SARS-CoV-2-positive and SARS-CoV-2-negative animals. (cdc.gov)
  • SARS-CoV-2 belongs to the family Coronaviridae and genus Betacoronavirus . (who.int)
  • Currently, there is no evidence to suggest that SARS-CoV-2 can infect aquatic food animals (e.g. finfish, crustaceans, mol uscs, amphibians) and therefore these animals do not play an epidemiological role in spreading COVID-19 to humans. (who.int)
  • Aquatic food animals and their products, like any other surface, may potential y become contaminated with SARS-CoV-2, especial y when handled by people who are infected with the virus. (who.int)
  • Nevertheless, with proper food handling and sanitation, the likelihood of contamination of aquatic animals or their products with SARS-CoV-2 should be negligible. (who.int)
  • Given the potential for fecal-oral SARS-CoV-2 transmission , the AASLD has joined multiple other societies in strongly recommending that nonurgent procedures (eg, endoscopy, liver biopsy, transient elastography) be rescheduled. (medscape.com)
  • They showed that this protective variant can reduce expression of the SARS-CoV-2 receptor and decrease COVID-19 risk. (cdc.gov)
  • La eficiencia catalítica es 400 veces mayor con la ANGIOTENSINA II como sustrato que con la ANGIOTENSINA I. La enzima convertidora de la angiotensina 2 también es un receptor funcional para la GLICOPROTEÍNA DE LAS ESPÍCULAS DE CORONAVIRUS de los CORONAVIRUS SARS-CoV, SARS-CoV2 y HCoV-NL63. (bvsalud.org)
  • Little is known about foetal impairment in mothers infected with SARS-CoV-2. (bvsalud.org)
  • The authors propose to evaluate the action of SARS-CoV-2 at the intrauterine level regarding the foetus' olfactory sensory impairment. (bvsalud.org)
  • There is a lack of data in the literature regarding foetal impairment by SARS-CoV-2. (bvsalud.org)
  • The results of this study will clarify whether intrauterine SARS-CoV-2 can affect the foetal sensory system or not. (bvsalud.org)
  • The natural history of COVID-19, caused by the SARThe natural history of COVID-19, caused by the SARS-CoV-2 virus, is still being explored. (bvsalud.org)
Astrocytes6
  • Objective: To investigate Angiotensin (Ang) II effect on Angiotensin Converting Enzyme (ACE) mRNA expression in cultured rat astrocytes isolated from spontaneous hypertensive rats (SHR) as compared to Wistar controls. (nova.edu)
  • Quiescent astrocytes were treated with 100nM Ang II at different time points. (nova.edu)
  • Results: Compared to basal ACE levels, Ang II significantly decreased ACE mRNA levels at most time points examined in CB and BS astrocytes isolated from SHR and Wistar rats. (nova.edu)
  • There was no significant difference at most time points between Ang II-induced ACE expression in SHR versus Wistar astrocytes. (nova.edu)
  • Moreover, ACE may have a key role in the auto-regulatory production of Ang II from Ang I in SHR and Wistar rat astrocytes. (nova.edu)
  • Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes. (wakehealth.edu)
Cleavage1
  • Angiotensin-Converting Enzyme 2 Ectodomain Shedding Cleavage-Site Identification: Determinants and Constraints. (acs.org)
Human1
  • Prior to the past two decades, the four circulating species of coronaviruses associated with human disease were known to be a significant cause of the common cold and other mild URIs. (thieme-connect.com)
Atherosclerotic1
  • Angiotensin II is produced primarily by angiotensin I-converting enzyme (ACE) within atherosclerotic lesions and ACE level in plaques correlates with the severity of vessel wall damage. (degruyter.com)
Epithelial cells1
  • ACE‐2 is a type I transmembrane metallocarboxypeptidase expressed in vascular endothelial cells, alveolar type 2 lung epithelial cells, renal tubular epithelium, Leydig cells in testes and gastrointestinal tract. (units.it)
Blood vessels1
Kidneys1
Sympathetic1
Genotypes1
  • There was a significant interaction (p = 0.033) between genotypes of ACE and angiotensin II type 1 receptor (AGTR1). (bmj.com)